Magne Henriksen
Sarpsborg, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Fatigue Trajectory During the First Year of an Inflammatory Bowel Disease Diagnosis, Results from the IBSEN III study.
Journal: Digestive diseases and sciences
Published: September 08, 2025
Predicting severe inflammatory bowel disease: a risk matrix model based on the IBSEN III inception cohort.
Journal: Scandinavian journal of gastroenterology
Published: June 08, 2025
Fecal Microbiome Reflects Disease State and Prognosis in Inflammatory Bowel Disease in an Adult Population-Based Inception Cohort.
Journal: Inflammatory bowel diseases
Published: October 07, 2024
Fatigue in Patients with Inflammatory Bowel Disease in Remission One Year After Diagnosis (the IBSEN III Study).
Journal: Journal of Crohn's & colitis
Published: August 30, 2024
Low Surgery Rates in Early Crohn's Disease: Results from a Prospective Population-Based Inception Cohort-The Inflammatory Bowel Disease in South-Eastern Norway III Study.
Journal: Inflammatory bowel diseases
Published: August 26, 2024
Clinical course of ulcerative colitis: Frequent use of biologics and low colectomy rate first year after diagnosis-results from the IBSEN III inception cohort.
Journal: Alimentary pharmacology & therapeutics
Published: January 10, 2024
Fatigue in Patients with Newly Diagnosed Inflammatory Bowel Disease: Results from a Prospective Inception Cohort, the IBSEN III Study.
Journal: Journal of Crohn's & colitis
Published: April 12, 2023
Antitumour necrosis factor alpha treatment in Crohn's disease: long-term efficacy, side effects and need for surgery.
Journal: Scandinavian journal of gastroenterology
Published: February 21, 2022
Inflammatory bowel disease in South-Eastern Norway III (IBSEN III): a new population-based inception cohort study from South-Eastern Norway.
Journal: Scandinavian journal of gastroenterology
Published: June 22, 2021
Outcome of Ulcerative Colitis 20 Years after Diagnosis in a Prospective Population-based Inception Cohort from South-Eastern Norway, the IBSEN Study.
Journal: Journal of Crohn's & colitis
Published: December 28, 2020
Efficacy and Safety of CT-P13 in Inflammatory Bowel Disease after Switching from Originator Infliximab: Exploratory Analyses from the NOR-SWITCH Main and Extension Trials.
Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Published: September 23, 2020
Risk of colorectal cancer in a population-based study 20 years after diagnosis of ulcerative colitis: results from the IBSEN study.
Journal: BMJ open gastroenterology
Published: December 15, 2019
Last Updated: 09/26/2026